A detailed history of Benedict Financial Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 42,646 shares of NVO stock, worth $5.99 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
42,646
Previous 43,664 2.33%
Holding current value
$5.99 Million
Previous $4.52 Million 21.21%
% of portfolio
1.4%
Previous 1.23%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$102.11 - $135.92 $103,947 - $138,366
-1,018 Reduced 2.33%
42,646 $5.48 Million
Q4 2023

Jan 29, 2024

SELL
$87.78 - $105.45 $55,125 - $66,222
-628 Reduced 1.42%
43,664 $4.52 Million
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $1.95 Million - $4.28 Million
21,457 Added 93.97%
44,292 $4.03 Million
Q2 2023

Aug 10, 2023

SELL
$155.98 - $172.65 $53,657 - $59,391
-344 Reduced 1.48%
22,835 $3.7 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $193,613 - $232,821
-1,463 Reduced 5.94%
23,179 $3.69 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $36,405 - $48,042
-355 Reduced 1.42%
24,642 $3.33 Million
Q3 2022

Nov 07, 2022

SELL
$95.28 - $116.93 $15,149 - $18,591
-159 Reduced 0.63%
24,997 $2.49 Million
Q2 2022

Jul 28, 2022

SELL
$103.24 - $121.81 $21,577 - $25,458
-209 Reduced 0.82%
25,156 $2.8 Million
Q1 2022

May 03, 2022

SELL
$93.1 - $112.54 $21,878 - $26,446
-235 Reduced 0.92%
25,365 $2.82 Million
Q4 2021

Feb 09, 2022

SELL
$95.88 - $117.08 $64,814 - $79,146
-676 Reduced 2.57%
25,600 $2.87 Million
Q3 2021

Oct 29, 2021

SELL
$84.42 - $106.62 $28,871 - $36,464
-342 Reduced 1.28%
26,276 $2.52 Million
Q2 2021

Aug 05, 2021

BUY
$67.66 - $84.76 $69,554 - $87,133
1,028 Added 4.02%
26,618 $2.23 Million
Q1 2021

May 10, 2021

BUY
$67.06 - $75.82 $35,474 - $40,108
529 Added 2.11%
25,590 $1.73 Million
Q4 2020

Feb 02, 2021

BUY
$63.89 - $73.8 $53,667 - $61,992
840 Added 3.47%
25,061 $1.75 Million
Q3 2020

Nov 03, 2020

BUY
$63.69 - $70.22 $34,965 - $38,550
549 Added 2.32%
24,221 $1.68 Million
Q2 2020

Jul 23, 2020

BUY
$58.54 - $67.94 $120,124 - $139,412
2,052 Added 9.49%
23,672 $1.55 Million
Q1 2020

Apr 21, 2020

BUY
$49.46 - $64.78 $451,322 - $591,117
9,125 Added 73.03%
21,620 $1.3 Million
Q4 2019

Feb 04, 2020

BUY
$49.86 - $58.26 $623,000 - $727,958
12,495 New
12,495 $723,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $317B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.